GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China Health Industries Holdings Inc (OTCPK:CHHE) » Definitions » Revenue

China Health Industries Holdings (China Health Industries Holdings) Revenue : $0.12 Mil (TTM As of Dec. 2023)


View and export this data going back to 2006. Start your Free Trial

What is China Health Industries Holdings Revenue?

China Health Industries Holdings's revenue for the three months ended in Dec. 2023 was $0.00 Mil. Its revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $0.12 Mil. China Health Industries Holdings's Revenue per Share for the three months ended in Dec. 2023 was $0.00. Its Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $0.00.

Warning Sign:

China Health Industries Holdings Inc revenue per share has been in decline over the past 3 years.

During the past 12 months, the average Revenue per Share Growth Rate of China Health Industries Holdings was 100.00% per year. During the past 3 years, the average Revenue per Share Growth Rate was -76.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate using Revenue per Share data.

During the past 13 years, China Health Industries Holdings's highest 3-Year average Revenue per Share Growth Rate was 75.20% per year. The lowest was -76.40% per year. And the median was -14.90% per year.


China Health Industries Holdings Revenue Historical Data

The historical data trend for China Health Industries Holdings's Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China Health Industries Holdings Revenue Chart

China Health Industries Holdings Annual Data
Trend Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9.28 9.93 6.49 - 0.11

China Health Industries Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.03 0.02 0.06 0.04 -

Competitive Comparison of China Health Industries Holdings's Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, China Health Industries Holdings's Revenue, along with its competitors' market caps and Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China Health Industries Holdings's Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China Health Industries Holdings's Revenue distribution charts can be found below:

* The bar in red indicates where China Health Industries Holdings's Revenue falls into.



China Health Industries Holdings Revenue Calculation

Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.

Revenue for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.12 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China Health Industries Holdings  (OTCPK:CHHE) Revenue Explanation

In ranking the predictability, companies with more consistent revenue and earnings growth are ranked high with predictability.

Peter Lynch categorized companies according to their revenue growth:


Slow Grower: Inflation < 10-Year Revenue Growth Rate < 10%:
Stalwart: 10% < 10-Year Revenue Growth Rate < 20%:
Fast Grower: 10-Year Revenue Growth Rate > 20%:

His favorite companies are stalwart, those growing between 10-20% a year.

Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.


Be Aware

Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.


China Health Industries Holdings Revenue Related Terms

Thank you for viewing the detailed overview of China Health Industries Holdings's Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


China Health Industries Holdings (China Health Industries Holdings) Business Description

Traded in Other Exchanges
N/A
Address
3199-1 Longxiang Road, Songbei District, Heilongjiang Province, Harbin, CHN, 150028
China Health Industries Holdings Inc operates in the health product industry and produces, markets and distributes medicines, health products, health devices and cosmetics. Its products series cover hemp-based food, hemp-based medicines, external used medicines and health food. The company has segmented its operating activities into three reportable segments, Humankind, HLJ Huimeijia, and Others. It generates maximum revenue from the Humankind segment.
Executives
Sun Xin director, 10 percent owner, officer: CEO, CFO and Treasurer NO 168 BINBEI STREET, SONBEI DISTRICT, HARBIN, HEI LONG JIANG F4 150000
Hall E Ewing director, officer: Secretary 2737 W BASELINE RD 22, TEMPE AZ 85283
Jack C Robinson director 16304 E COUNTRY SHADOW CT, LILBEAT AZ 85297
Teri S Foster director 402 CANDOVER COURT, KATY TX 77450
Brian Lee Hahn director, officer: COO 422 LAMONT TERRACE, BUFFALO GROVE IL 60089
Dennis Mckee 10 percent owner 3522 DOHERTY PLACE, KATY TX 77449
Thomas Allen Bontems 10 percent owner, officer: President, CEO, CFO and, other: Secretary 1808 S. 1ST AVENUE, PHONEIX AZ 85003

China Health Industries Holdings (China Health Industries Holdings) Headlines

No Headlines